Clear Search

Showing 1 result for “Sherif B”.

March 2022

Effetto di secukinumab sugli esiti riportati dai pazienti in pazienti con artrite psoriasica attiva in uno studio randomizzato di fase 3

Lancet. 2022. Epub ahead of print

Predefined analysis of FUTURE 5, the largest Phase 3 randomised trial of secukinumab in patients with PsA to date, demonstrates that secukinumab results in early, statistically significant, clinically meaningful, sustained improvements in PROs across all doses, compared with placebo.The fully human anti-interleukin 17A monoclonal antibody, secukinumab has shown clinical and radiographical efficacy in patients with PsA, yet the clinical significance of improvements across a wide variety of PROs r...

di più…